| Retinoic Acid Receptor Beta | |
|---|---|
| Protein Name | Retinoic Acid Receptor Beta |
| Gene Symbol | [RARB](/genes/rarb) |
| UniProt ID | [P10826](https://www.uniprot.org/uniprot/P10826) |
| PDB Structures | 5KJ6, 5XIN, 3A9E |
| Molecular Weight | ~50 kDa |
| Subcellular Localization | Nucleus |
| Protein Family | Nuclear Receptor Family, Retinoic Acid Receptor Subfamily |
| Endogenous Ligand | All-trans retinoic acid (ATRA) |
Retinoic Acid Receptor Beta (RARB) is a ligand-activated transcription factor belonging to the nuclear receptor superfamily, mediating the genomic effects of all-trans retinoic acid (ATRA) and related retinoids[1]. RARB regulates genes controlling neuronal differentiation, synaptic plasticity, memory formation, and cell survival — pathways directly relevant to Alzheimer's Disease and Parkinson's Disease[2]. RARB dysfunction contributes to neurodegeneration through impaired neuronal resilience and altered amyloid metabolism, while RARB agonists show neuroprotective effects in cellular and animal models[3].
The RARB gene is located on chromosome 3p24 and encodes multiple isoforms through alternative promoter usage and splicing. Human RARB produces at least 4 major isoforms (RARB1-RARB4) with distinct N-terminal regions and expression patterns. RARB2 (also called RAR-beta2) is the predominant isoform in the CNS, highly expressed in hippocampus, cortex, and substantia nigra. Expression is dynamically regulated by retinoid levels, neuronal activity, and during brain development.
RARB adopts the canonical nuclear receptor modular architecture[4]:
DNA-Binding Domain (DBD): Located at the N-terminus, contains two zinc-finger motifs that:
Hinge Region: Flexible linker connecting DBD to LBD, contains a nuclear localization signal (NLS), and allows conformational flexibility important for cofactor recruitment
Ligand-Binding Domain (LBD): The C-terminal portion:
Normal Function:
RARB functions as a heterodimer with RXR (typically RXRalpha) on DNA. The RARB-RXR heterodimer binds RAREs and:
RARB target genes include those involved in:
RARB is implicated in AD through multiple mechanisms[2:1]:
Retinoid Signaling Deficiency: Evidence suggests impaired retinoic acid signaling contributes to AD pathogenesis:
Effects on Amyloid Metabolism: RARB agonists modulate APP processing:
Neuronal Survival: RARB target genes include neurotrophic factors and anti-apoptotic genes:
Cognitive Function: Retinoid signaling is required for hippocampal memory formation:
RARB signaling is relevant to PD pathogenesis and therapy[3:1]:
Dopaminergic Neuron Survival: ATRA and RARB agonists protect dopaminergic neurons:
Neuroinflammation: Retinoids have immunomodulatory effects:
L-DOPA Metabolism: Some evidence suggests retinoid signaling influences dopamine synthesis and metabolism:
All-trans retinoic acid (ATRA) is the prototypical RARB agonist[4:1]:
Selective RARB agonists (e.g., AC261066, BrP) are being developed with:
RXR agonists (bexarotene) also activate RARB-containing heterodimers and have been tested in AD models, though results have been mixed.
Retinoid therapy faces significant obstacles:
| Protein | Interaction Type | Functional Significance |
|---|---|---|
| RXRalpha | Heterodimerization | Required for DNA binding and function |
| NCoR | Corepressor binding | Represses transcription in absence of ligand |
| SMRT | Corepressor binding | Represses transcription in absence of ligand |
| SRC-1 (NCOA1) | Coactivator binding | Recruited upon ligand binding, activates transcription |
| p300/CBP | Coactivator binding | Histone acetylation, transcriptional activation |
| HDAC3 | Corepressor complex | Histone deacetylation, chromatin condensation |
| MED1 | Coactivator complex | Transcriptional coactivator mediator subunit |
Maden M. Retinoic acid in the developing and adult nervous system. Trends in Neurosciences. 2001. ↩︎
Goodman AB, et al. Retinoid receptors as therapeutic targets in Alzheimer's disease. Journal of Neurochemistry. 2012. ↩︎ ↩︎
Sasse S, et al. Retinoic acid signaling in Parkinson's disease. Cellular and Molecular Neurobiology. 2013. ↩︎ ↩︎
McIlroy GD, et al. Retinoic acid and the vitamin D receptor: new ligands for neuroprotective signaling. Molecular Endocrinology. 2013. ↩︎ ↩︎
Krezel W, et al. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Neuron. 1999. ↩︎ ↩︎